Isolation of Oct4 +, Nanog + and SOX2 - mesenchymal cells from peripheral blood of a diabetes mellitus patient

Human Cell

Volumn 24, Issue 1, 2011, Pages 51-55

  Potdar, Pravin D ^a   D'souza, Stephanie B ^a  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Circulating progenitor cells; Diabetes mellitus; Mesenchymal stem cells; Stem cell markers; Stem cell therapy

Indexed keywords

CD45 ANTIGEN; ENDOGLIN; MICROSOMAL AMINOPEPTIDASE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL MIGRATION; DIABETES MELLITUS; DIABETIC PATIENT; GENE CONTROL; HUMAN; HUMAN CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, CD45; BIOLOGICAL MARKERS; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; RECEPTORS, CELL SURFACE; SOXB1 TRANSCRIPTION FACTORS;

EID: 79952955745     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-011-0011-6     Document Type: Article

References (8)

1. Ulicna M, Danisovic L, Danihel L, Vojtassak J, et al. Diabetes--adult stem cells as an future alternative therapy? Bratisl Lek Listy. 2009; 110: 773-6.
2. Zulweski H. Stem cells with potential to generate insulin-producing cells in man. Swiss Med Wkly. 2006; 136: 647-54.
3. Cesselli D, Beltrami AP, Rigo S. Multipotent progenitor cells are present in human peripheral blood. Circ Res. 2009; 104: 1225-34.
4. Tondreau T, Meuleman N, Delforge A. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005; 23: 1105-12.
5. Potdar PD, Sutar JP. Establishment and molecular characterization of mesenchymal stem cells derived from human visceral and subcutaneous adipose tissues. JSRM. 2010. Available at: http://www. pubstemcell. com/monthly/uploads/006010300005. htm.
6. Zhang D, Efendic S, Brismar K, Gu HF. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 diabetes mellitus. BMC Med Genet. 2010; 11: 116.
7. Yu S, Li C, Xin-guo H, Wei-kai H, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J. 2007; 120: 771-6.
8. Ichim TE, Solano F, Glenn E, et al. Stem cell therapy for autism. J Transl Med. 2007; 5: 1-9.